Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS/MS and probabilistic peptide scoring.
A protein of a biological sample is usually quantified by immunological techniques based on antibodies. Mass spectrometry offers alternative approaches that are not dependent on antibody affinity and avidity, protein isoforms, quaternary structures, or steric hindrance of antibody-antigen recognition in case of multiprotein complexes. One approach is the use of stable isotope-labeled internal standards; another is the direct exploitation of mass spectrometric signals recorded by LC-MS/MS analysis of protein digests. Here we assessed the peptide match score summation index based on probabilistic peptide scores calculated by the PHENYX protein identification engine for absolute protein quantification in accordance with the protein abundance index as proposed by Mann and co-workers (Rappsilber, J., Ryder, U., Lamond, A. I., and Mann, M. (2002) Large-scale proteomic analysis of the human spliceosome. Genome Res. 12, 1231-1245). Using synthetic protein mixtures, we demonstrated that this approach works well, although proteins can have different response factors. Applied to high density lipoproteins (HDLs), this new approach compared favorably to alternative protein quantitation methods like UV detection of protein peaks separated by capillary electrophoresis or quantitation of protein spots on SDS-PAGE. We compared the protein composition of a well defined HDL density class isolated from plasma of seven hypercholesterolemia subjects having low or high HDL cholesterol with HDL from nine normolipidemia subjects. The quantitative protein patterns distinguished individuals according to the corresponding concentration and distribution of cholesterol from serum lipid measurements of the same samples and revealed that hypercholesterolemia in unrelated individuals is the result of different deficiencies. The presented approach is complementary to HDL lipid analysis; does not rely on complicated sample treatment, e.g. chemical reactions, or antibodies; and can be used for projective clinical studies of larger patient groups.
Heller
Manfred
M
Laboratory of Thrombosis Research, Department of Clinical Research, University of Bern, Switzerland. manfred.heller@dkf.unibe.ch
Schlappritzi
Evelyn
E
Stalder
Daniel
D
Nuoffer
Jean-Marc
JM
Haeberli
André
A
D000818:Animals; D016632:Apolipoprotein A-I / Q000032:analysis; D002853:Chromatography, Liquid; D019295:Computational Biology / Q000379:methods*; D019075:Electrophoresis, Capillary; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D008075:Lipoproteins, HDL / Q000032:analysis* / Q000737:chemistry / Q000302:isolation & purification; D008297:Male; D013058:Mass Spectrometry; D010455:Peptides / Q000737:chemistry*; D015203:Reproducibility of Results; D012984:Software
D016632:Apolipoprotein A-I; D008075:Lipoproteins, HDL; D010455:Peptides